Isu Abxis Rises 7.1% Amid Uptrend in Immuno-Oncology Theme

On the 5th, the immuno-oncology theme rose 3.01% compared to the previous day, showing strength, while Isu Abxis, a related stock drawing attention, surged 7.1% compared to the previous day. Isu Abxis is known as an affiliate of the Isu Group, developing antibiotic treatments and providing medical services.

[Graph] Price Fluctuations of Major Stocks in the Immuno-Oncology Theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Isu Abxis’s quant financial score was 7.04 points, ranking 16th in the quant financial ranking within the immuno-oncology theme. This can be interpreted as Isu Abxis having relatively low investment attractiveness from a financial perspective. On the other hand, Dong-A ST ranked first in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Score within the Theme


※ The quant financial score is the result of the robo algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.